Cargando…
Exploring synthetic and therapeutic prospects of new thiazoline derivatives as aldose reductase (ALR2) inhibitors
Inhibition of aldose reductase (ALR2) by using small heterocyclic compounds provides a viable approach for the development of new antidiabetic agents. With our ongoing interest towards aldose reductase (ALR2) inhibition, we have synthesized and screened a series of thiazoline derivatives (5a–k, 6a–f...
Autores principales: | Shehzad, Muhammad Tariq, Imran, Aqeel, Hameed, Abdul, Rashida, Mariya al, Bibi, Marium, Uroos, Maliha, Asari, Asnuzilawati, Iftikhar, Shafia, Mohamad, Habsah, Tahir, Muhammad Nawaz, Shafiq, Zahid, Iqbal, Jamshed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033183/ https://www.ncbi.nlm.nih.gov/pubmed/35479726 http://dx.doi.org/10.1039/d1ra01716k |
Ejemplares similares
-
Development, Molecular
Docking, and In Silico ADME Evaluation of Selective
ALR2 Inhibitors for the Treatment of
Diabetic Complications via Suppression of the Polyol
Pathway
por: Imran, Aqeel, et al.
Publicado: (2022) -
Development and exploration of novel substituted thiosemicarbazones as inhibitors of aldose reductase via in vitro analysis and computational study
por: Imran, Aqeel, et al.
Publicado: (2022) -
Vitamin K1 prevents diabetic cataract by inhibiting lens aldose reductase 2 (ALR2) activity
por: Thiagarajan, R., et al.
Publicado: (2019) -
Utilization of transition metal fluoride-based solid support catalysts for the synthesis of sulfonamides: carbonic anhydrase inhibitory activity and in silico study
por: Ali, Deedar, et al.
Publicado: (2022) -
Polymorphisms of Aldose Reductase (ALR2) Regulatory Gene are Risk Factors for Diabetic Retinopathy in Type-2 Diabetes Mellitus Patients in Bali, Indonesia
por: Wihandani, Desak Made, et al.
Publicado: (2018)